Cipla

Cipla Partners Kemwell & Manipal for Global Cell Therapy Advancements January 9, 2024 Global pharmaceutical company Cipla has joined hands with Kemwell Biopharma and Manipal Education & Medical Group in the US. The joint venture seeks to expedite the development, manufacturing, and distribution of cell therapies.

Top Acquisitions that Hit The Pharma Industry in 2023 December 28, 2023 At the heart of this transformative journey were the noteworthy acquisitions that left an indelible mark on the pharma landscape. Let's take a closer look at some of the top acquisitions that shaped the pharma sector in 2023.

Cipla Invests Additional $5.04 Mn in GoApptiv to Enhance Digital Healthcare Access December 19, 2023 The journey began in June 2020 when Cipla initially acquired a 21.85% stake in GoApptiv for INR 9 Cr. Over the following two years, Cipla progressively increased its stake to 22.02%, investing INR 25.90 Cr.

Torrent Pharmaceuticals Secures $5 Bn Funds for Cipla Deal October 23, 2023 Indian pharmaceutical major, Torrent Pharmaceuticals has lined up at least $5 billion in funding to take over its rival Cipla Ltd.

Cipla Stake Sale Plan Faces Indecision Amidst Valuation Disagreements October 10, 2023 The ongoing buzz surrounding the Cipla acquisition has taken a new turn, with promoters disagreements on the company's valuation figure.

Cipla Foundation, NIMHANS Partners to Set Up Neuro-Palliative Care Unit October 5, 2023 In partnership with the Cipla Foundation, the National Institute of Mental Health and Neuro-Sciences (NIMHANS) has launched a neuro-palliative care unit in Bengaluru. 

Cipla is in Advanced Talks with Companies to Sell 60% Stake September 29, 2023 Following a series of collaborative efforts and funding preparation to acquire Cipla, the country's third-largest drugmaker has finally come to the field. It's now in discussion with two consortiums to sell a controlling 60% stake.

Cipla Joins Hands with Skye Air Mobility to Offer Drone-Powered Medicine Delivery in HP September 27, 2023 The primary goal is to ensure prompt delivery of medications to pharmacies and clinics in remote regions while minimising the potential risks associated with temperature fluctuations that could affect cold chain products.

Torrent Pharma Now in talks with Apollo Global Management to borrow up to $1 Billion for Cipla bid September 20, 2023 Ahmedabad-based Torrent Pharmaceuticals has recently entered into preliminary discussions with Apollo Global Management to obtain a loan of up to $1 billion to acquire rival company Cipla.

Torrent Pharma Looks to Partner with CVC Capital to Aquire Cipla September 18, 2023 Ahmedabad-based Torrent Pharmaceuticals has entered into advanced negotiations with Luxembourgs CVC Capital Partners to raise investment estimated around $1.2-1.5 billion for its proposed acquisition of rival company Cipla.

Cipla to Acquire South African OTC Pharma Leader Actor Pharma September 5, 2023 Cipla South Africa, a subsidiary of Ace Mumbai-based pharmaceutical company Cipla, has officially signed a binding term sheet to acquire Actor Pharma, a prominent player in the over-the-counter (OTC) and generic medicine sector.

Cipla Launches CiplaMed 2.0, a Knowledge Platform for Healthcare Professionals       August 21, 2023 In a deal with BlackSoil, a prominent investment firm, GenWorks Health has received $4 million in funding. Through this investment, GenWorks Health can provide quality healthcare in underserved areas.